TickerFactsScreenerDevelopers

Ernexa Therapeutics Inc. (ERNA) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2009: $9.42M2010: $9.46M2011: $6.35M2012: $7.89M2013: $9.20M2014: $10.92M2015: $3.85M2016: $4.07M2017: $5.54M2018: $6.92M2019: $9.74M2020: $7.66M2021: $25.50M2022: $12.11M2023: $2.23M2024: $1.70M2025: $2.40M$2.40M
2009Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$2.40M+41.2%
2024$1.70M-23.8%
2023$2.23M-81.6%
2022$12.11M-52.5%
2021$25.50M+233.0%
2020$7.66M-21.4%
2019$9.74M+40.9%
2018$6.92M+24.9%
2017$5.54M+36.1%
2016$4.07M+5.7%
2015$3.85M-64.8%
2014$10.92M+18.7%
2013$9.20M+16.6%
2012$7.89M+24.3%
2011$6.35M-32.9%
2010$9.46M+0.5%
2009$9.42M—